SCHEMBL6981983

SCHEMBL6981983

N#Cc1ccc(CCC(=O)N2CCCc3cc(NCC(=O)c4ccccc4)ccc32)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.46
ALDH1A1 P00352 2/20 0.45
TP53 P04637 3/20 0.42
FPR1 P21462 2/20 0.42
FPR2 P25090 2/20 0.42
TSHR P16473 2/20 0.42
MEN1 O00255 1/20 0.42
USP2 O75604 1/20 0.42
HPGD P15428 1/20 0.42
KMT2A Q03164 1/20 0.42
HSD17B10 Q99714 1/20 0.42
NR3C1 P04150 2/20 0.42
LMNA P02545 1/20 0.41
HDAC1 Q13547 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
AR P10275 1/20 0.40
AKR1C3 P42330 1/20 0.39
PARP1 P09874 1/20 0.39
NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6984804 0.91 KCNH2 (0.45) ALDH1A1TP53FPR1FPR2LMNA
SCHEMBL6976631 0.88 HSD17B3 (0.46) RAB9AALDH1A1TP53FPR1FPR2
SCHEMBL6985377 0.87 RAB9A (0.62) RAB9AALDH1A1TP53FPR1FPR2
SCHEMBL6981023 0.87 RAB9A (0.45) RAB9AALDH1A1TP53NR3C1LMNA
Hydrochloric Acid SCHEMBL6981077 0.86 RAB9A (0.44) RAB9AALDH1A1TP53NR3C1LMNA
SCHEMBL6983653 0.86 FPR1 (0.44) RAB9AALDH1A1TP53FPR1FPR2
SCHEMBL6985394 0.85 ALDH1A1 (0.41) RAB9AALDH1A1TP53FPR1FPR2
SCHEMBL6984731 0.85 TP53 (0.45) RAB9AALDH1A1TP53FPR1FPR2
SCHEMBL6986003 0.84 RAB9A (0.48) RAB9AALDH1A1TP53FPR1FPR2
SCHEMBL6976871 0.84 FFAR1 (0.49) RAB9AALDH1A1TP53FPR1FPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed